Jing Wang1
Qiu Fang
Xuemei Luo
Lu Jin
Huaijun Zhu
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
- 2Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
A Corrigendum on
Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients
by Wang J, Fang Q, Luo X, Jin L and Zhu H (2025). Front. Pharmacol. 15:1524272. doi:10.3389/fphar.2024.1524272
In the published article, there was an error in Affiliation 1. Instead of “Department of Pharmacy, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China,” it should be “Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.”
In the published article, there was an error regarding the Affiliation of “Huaijun Zhu”. As well as having affiliation 1, they should also have “Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.”
The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: imipenem, population pharmacokinetics, dosing optimization, elderly patients, Monte Carlo
Citation: Wang J, Fang Q, Luo X, Jin L and Zhu H (2025) Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients. Front. Pharmacol. 16:1565995. doi: 10.3389/fphar.2025.1565995
Received: 24 January 2025; Accepted: 05 February 2025;
Published: 14 February 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Wang, Fang, Luo, Jin and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huaijun Zhu, aHVhaWp1bi56aHVAZ21haWwuY29t